MedTrace Logo

Registry of Patients With a Bioabsorbable Magnesium Stent Implant MAGMARIS in Usual Clinical Practice

NCT03413813 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 262

Last updated 2021-07-15

No results posted yet for this study

Summary

The safety and efficacy of percutaneous coronary revascularization has been progressively increasing since its inception, and the problem of restenosis has been minimized.

The efficacy and safety data of the Magmaris stent are quite high, in selected cases.

The objective is to evaluate the efficacy and safety of the bioabsorbable stent MAGMARIS in the percutaneous treatment of severe coronary disease (in vessels between 2.7mm and 3.75 mm) in routine clinical practice in poorly selected populations.

Conditions

Interventions

DEVICE

Magmaris

Severe stenosis de novo, in native coronary arteries, treated with percutaneous coronary intervention with scaffold implantation.

Sponsors & Collaborators

  • Spanish Society of Cardiology

    lead OTHER

Principal Investigators

  • Andres I Romo, MD, PhD · Spanish Society of Cardiology

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-26
Primary Completion
2021-06-07
Completion
2021-06-07

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413813 on ClinicalTrials.gov